All items are in the Adobe® PDF format. You may download a complimentary version of the Adobe Reader by clicking here.
For more information on any of our regular publications, or to subscribe to one of our newsletters, please fill out our newsletter subscription form.
First PTAB Reversals Under New Subject Matter Eligibility Guidance. IP Watchdog. 02/15/2019 (Aseet Patel, Craig W. Kronenthal)
|Athena v. Mayo: Are pure diagnostic claims per se ineligible for patenting?. Banner & Witcoff IP Alert 02/08/2019 (Sarah A. Kagan-Ph.D.)
|First PTAB Decision Reversing Examiner Under New Subject Matter Eligibility Guidance. Banner & Witcoff IP Alert 02/02/2019 (Aseet Patel, Craig W. Kronenthal)
|Endo v. Teva: Courts Continue to Invalidate Patent Claims Without Construing Them. Banner & Witcoff IP Alert. 12/21/2018 (Sarah A. Kagan-Ph.D.)
|Clarifying Multi-Embodiment And Single-View Design Filings. Law360 Expert Analysis. 07/14/2018 (Alisa S. Abbott, Bradley J. Van Pelt)
|In IPR, a Picture is Worth a Thousand Words … or Worse than Worthless. Banner & Witcoff PTAB Highlights. 12/12/2018 (Charles W. Shifley)
|Patent Law Year in Review 2018 Presentation. Presented to The D.C. Bar. 12/11/2018 (Scott M. Kelly)
|EU Court Finds There’s No Accounting for Taste in Copyright Lawsuit. Banner & Witcoff IP Alert. 12/11/2018 (Liz Brodzinski)
|Helsinn v. Teva at the Supreme Court: Did the America Invents Act Change the On-Sale Bar?. Banner & Witcoff IP Alert. 12/5/2018 (Sarah A. Kagan-Ph.D.)
|Allergan v. Teva Pharmaceuticals USA: Will the Recognized Commercial Success of Restasis® Demonstrate Non-Obviousness?. Banner & Witcoff IP Alert. 12/3/2018 (Sarah A. Kagan-Ph.D.)
|